Latest News & Features
Refine Search
Medtech
 The EU General Court today upheld the decision to invalidate a trademark owned by Swemac Innovation, a Swedish medical devices company.   7 February 2019 
Americas
 A US jury has ordered pharmaceutical company Baxalta Inc. to pay $155 million to Bayer Healthcare following a patent infringement trial.   6 February 2019 
Americas
 UK headquartered GSK has made another move in the oncology space, signing a potential €3.7 billion immunotherapy deal with Germany-based Merck KGaA.   6 February 2019 
Americas
 Rivals of British pharmaceutical company Indivior will soon be able to sell generic versions of opioid addiction treatment Suboxone film following a ruling of the US Court of Appeals for the Federal Circuit.   5 February 2019 
Big Pharma
 The Philippines Food and Drug Administration has issued a closure notice for a company allegedly responsible for producing counterfeit rabies vaccines.   4 February 2019 
Americas
 Generic-drug manufacturers Mylan Pharmaceuticals, Breckenridge Pharmaceutical and Alembin Pharmaceuticals have lost their bid to prove that claims in a patent owned by US company Research Corporation Technologies, were invalid on the grounds of obviousness.   4 February 2019 
Asia-Pacific
 Chinese artificial intelligence start-up Yitu Technology has launched a new research and development centre in Singapore which will focus partly on applying the technology to medical diagnostics.   1 February 2019 
Big Pharma
 American pharmaceutical company Pfizer warned investors of little revenue growth to come in 2019, owing partly to expiring exclusivity rights on drugs including Viagra and the seizure medicine Lyrica.   31 January 2019 
Americas
 Global biopharmaceutical company Celgene has signed a collaboration deal worth up to nearly $1 billion to develop a preclinical therapeutic for the treatment of blood cancers, including leukaemia.   31 January 2019 
Americas
 A record number of novel devices were approved by the US Food and Drug Administration in 2018, the federal agency has said.   31 January 2019 


